Remove Disease Remove Pharmacy Remove Specialty Pharmacies
article thumbnail

Informa Connect's Hub and Specialty Pharmacy Models West

Drug Channels

Informa Connect's Hub and Specialty Pharmacy Models West. September 14-15, 2022 Sheraton San Diego Hotel & Marina | San Diego, CA www.informaconnect.com/hub-specialty-pharmacy-west. Delivered as a Hybrid Event. Drug Channels readers will save 10% off the current registration rate when they use code 22DC10 *.

article thumbnail

Informa Connect’s Access USA

Drug Channels

Access USA will unite PAP – Patient Assistance & Access Programs, Hub and Specialty Pharmacy Models East and Rare Disease Innovation & Partnership Summit, three industry-leading access conferences under one roof for one week of collaborative discussions and opportunities to expand your network and establish powerful partnerships.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Informa Connect’s Access USA

Drug Channels

Access USA will unite PAP – Patient Assistance & Access Programs, Hub and Specialty Pharmacy Models East and the Rare Disease Summit three influential access conferences under one roof for one week of collaborative discussions and opportunities to expand your network and establish powerful partnerships. What is Access USA?

article thumbnail

Accelerating Patient Identification and Improving Health Outcomes for Orphan Drug Candidates in Europe.

Fierce BioTech

With rare diseases, every patient is different, and every journey is unique. In this webinar we hear from industry leaders, including a leading specialty pharmacy in Europe, on how they provide healthcare services including digital solutions to people living with a rare disease, to help them get the best outcomes from their medication.

article thumbnail

Informa Connect’s Hub, SPP and eServices Optimization

Drug Channels

This important event convenes key stakeholders including manufacturers, specialty pharmacies, hub providers and more for unrivaled collaboration to leverage innovation and optimize access. In-Person: Sep 22-23, New Brunswick, NJ | Virtual: Sep 28-29 www.informaconnect.com/hub-spp/.

article thumbnail

The three key stages to a successful specialty drug launch

Drug Discovery World

However, if starting earlier is not an option, then organisations should place express focus on communicating why treatment of the disease matters. And, finally let’s not forget the importance of activities you’ve been working on for the past 12 months or so to communicate why treatment of the disease matters and how you will deliver.

article thumbnail

FDA Approves Zokinvy (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies

The Pharma Data

Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that the U.S. Progeria and Progeroid Laminopathies are separate and distinct ultra-rare, genetic, premature aging diseases that accelerate mortality in young patients. PALO ALTO, Calif.,